Gender-specific expression of liver organic anion transporters in rat

European Journal of Clinical Investigation

Volumn 35, Issue 10, 2005, Pages 635-643

  Rost, Daniel ^a,c   Kopplow, K ^b   Gehrke, S ^a   Mueller, S ^a   Friess, H ^a   Ittrich, C ^b   Mayer, D ^b   Stiehl, A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Gender; Liver; Organic anion transporter; Rat

Indexed keywords

CARRIER PROTEIN; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 2; ORGANIC ANION TRANSPORTER 4; PRASTERONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENDER; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; LIVER METABOLISM; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR;

ANIMALS; DEHYDROEPIANDROSTERONE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOBLOTTING; LIVER; MALE; MITOCHONDRIAL PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; ORGANIC ANION TRANSPORTERS; P-GLYCOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEINS; RNA, MESSENGER; SACCHAROMYCES CEREVISIAE PROTEINS; SEX CHARACTERISTICS;

EID: 26044480423     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2005.01556.x     Document Type: Article

References (57)

1. Kando JC, Yonkers KA, Cole JO. Gender as a risk factor for adverse events to medications. Drugs 1995;50:1-6.
2. Tran C, Knowles SR, Liu BA, Shear NH. Gender differences in adverse drug reactions. J Clin Pharmacol 1998;38:1003-9.
3. Thurmann PA, Hompesch BC. Influence of gender on the pharmacokinetics and pharmacodynamics of drugs. Int J Clin Pharmacol Ther 1998;36:586-90.
4. Harris RZ, Benet LZ, Schwartz JB. Gender effects in pharmacokinetics and pharmacodynamics. Drugs 1995;50:222-39.
5. Kusuhara H, Sugiyama Y. Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney. J Control Release 2002;78:43-54.
6. Bodo A, Bakos E, Szeri F, Varadi A, Sarkadi B. The role of multidrug transporters in drug availability, metabolism and toxicity. Toxicol Lett 2003;140-141:133-43.
7. Meier PJ, Stieger B. Bile salt transporters. Annu Rev Physiol 2002;64:635-61.
8. Hagenbuch B, Meier PJ. The superfamily of organic anion transporting polypeptides. Biochem Biophys Acta 2003;1609:1-18.
9. Kim RB. Organic anion-transporting polypeptide (OATP) transporter family and drug disposition. Eur J Clin Invest 2003;33 (Suppl. 2):1-5.
10. Lu R, Kanai N, Bao Y, Wolkoff AW, Schuster VL. Regulation of renal Oatp mRNA expression by testosterone. Am J Physiol 1996;270:332-7.
11. Kato Y, Kuge K, Kusuhara H, Meier PJ, Sugiyama Y. Gender difference in the urinary excretion of organic anions in rats. J Pharmacol Exp Ther 2002;302:483-9.
12. Gotoh Y, Kato Y, Stieger B, Meier PJ, Sugiyama Y. Gender difference in the Oatp1-mediated tubular reabsorption of estradiol 17beta-D-glucuronide in rats. Am J Physiol Endocrinol Metab 2002;282:E1245-54.
13. Martin JF, Mikulecky M, Blaschike TF, Waggoner JG, Vergalla J, Berk PD. Differences between the plasma indocyanine green disappearance rates of normal men and women. Proc Soc Exp Biol Med 1975;150:612-7.
14. Orzes N, Bellentani S, Aldini R, Simoni P, Ferretti I, Lunazzi GC et al. Sex differences in the hepatic uptake of sulphobromophthalein in the rat. Clin Sci (Lond) 1985;69:587-93.
15. Muraca M, de Groote J, Fevery J. Sex differences of hepatic conjugation of bilirubin determines its maximal biliary excretion in non-anaesthetized male and female rats. Clin Sci (Lond) 1983;64:85-90.
16. Keppler D, Kamisako T, Leier I, Cui Y, Nies AT, Tsujii H et al. Localization, substrate specificity, and drug resistance conferred by conjugate export pumps of the MRP family. Adv Enzyme Regul 2000;40:339-49.
17. Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 2000;92:1295-302.
18. Kruh GD, Belinsky MG. The MRP family of drug efflux pumps. Oncogene 2003;22:7537-52.
19. Hirohashi T, Suzuki H, Ito K, Ogawa K, Kume K, Shimizu T et al. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats. Mol Pharmacol 1998;53:1068-75.
20. Soroka CJ, Lee JM, Azzaroli F, Boyer JL. Cellular localization and upregulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology 2001;33:783-91.
21. Konig J, Rost D, Cui Y, Keppler D. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 1999;29:1156-63.
22. Kroboth PD, Salek FS, Pittenger AL, Fabian TJ, Frye RF. DHEA and DHEAS: a review. J Clin Pharmacol 1999;39:327-48.
23. Reuter S, Mayer D. Transport of dehydroepiandrosterone and dehydroepiandrosterone sulphate into rat hepatocytes. J Steroid Biochem Mol Biol 1995;54:227-35.
24. Cattori V, van Montfoort JE, Stieger B, Landmann L, Meijer DK, Winterhalter KH et al. Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3. Pflugers Arch 2001;443:188-95.
25. Kullak-Ublick GA, Fisch T, Oswald M, Hagenbuch B, Meier PJ, Beuers U et al. Dehydroepiandrosterone sulfate (DHEAS): identification of a carrier protein in human liver and brain. FEBS Lett 1998;424:173-6.
26. Zelcer N, Reid G, Wielinga P, Kuil A, van der Heijden I, Schuetz JD et al. Steroid and bile acid conjugates are substrates of human multidrug-resistance protein MRP 4 (ATP-binding cassette C4). Biochem J 2003;371:361-7.
27. Cui Y, Konig J, Keppler D. Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol Pharmacol 2001;60:934-43.
28. Buchler M, Konig J, Brom M, Kartenbeck J, Spring H, Horie T et al. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem 1996;271:15091-8.
29. +-independent organic anion transporting polypeptide (Oatp-1) in rats with bile duct ligation. J Hepatol 1997;27:1051-6.
30. Reichel C, Gao B, Van Montfoort J, Cattori V, Rahner C, Hagenbuch B et al. Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver. Gastroenterology 1999;117:688-95.
31. Ogawa K, Suzuki H, Hirohashi T, Ishikawa T, Meier PJ, Hirose K et al. Characterization of inducible nature of MRP3 in rat liver. Am J Physiol Gastrointest Liver Physiol 2000;278:G438-46.
32. Rost D, Kartenbeck J, Keppler D. Changes in the localization of the rat canalicular conjugate export pump Mrp2 in phalloidin-induced cholestasis. Hepatology 1999;29:814-21.
33. Rost D, Herrmann T, Sauer P, Schmidts HL, Stieger B, Meier PJ et al. Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate. Hepatology 2003;38:187-95.
34. R Development Core Team R. A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2005.
35. Harrell FE. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer;2001.
36. Bretz F, Genz A, Hothorn LA. On the numerical availability of multiple comparison procedures. Biometrical Journal 2001;43:64-6.
37. Holm S. A simple sequentially rejective multiple test procedure. Scand J Statist 1979;6:65-70.
38. Buist SC, Cherrington NJ, Choudhuri S, Hartley DP, Klaassen CD. Gender-specific and developmental influences on the expression of rat organic anion transporters. J Pharmacol Exp Ther 2002;301:145-51.
39. Kobayashi Y, Hirokawa N, Ohshiro N, Sekine T, Sasaki T, Tokuyama S et al. Differential gene expression of organic anion transporters in male and female rats. Biochem Biophys Res Commun 2002;290:482-7.
40. Buist SC, Cherrington NJ, Klaassen CD. Endocrine regulation of rat organic anion transporters. Drug Metab Dispos 2003;31:559-64.
41. Simon FR, Fortune J, Iwahashi M, Bowman S, Wolkoff A, Sutherland E. Characterization of the mechanisms involved in the gender differences in hepatic taurocholate uptake. Am J Physiol 1999;276:G556-65.
42. Li N, Hartley DP, Cherrington NJ, Klaassen CD. Tissue expression, ontogeny, and inducibility of rat organic anion transporting polypeptide 4. J Pharmacol Exp Ther 2002;301:551-60.
43. Brock WJ, Vore M. Characterization of uptake of steroid glucuronides into isolated male and female rat hepatocytes. J Pharmacol Exp Ther 1984;229:175-81.
44. Keppler D, Konig J. Hepatic secretion of conjugated drugs and endogenous substances. Semin Liver Dis 2000;20:265-72.
45. Kamisako T, Leier I, Cui Y, Konig J, Buchholz U, Hummel-Eisenbeiss J et al. Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2. Hepatology 1999;30:485-90.
46. Xiong H, Yoshinari K, Brouwer KL, Negishi M. Role of constitutive androstane receptor in the in vivo induction of Mrp3 and CYP2B1/2 by phenobarbital. Drug Metab Dispos 2002;30:918-23.
47. Cherrington NJ, Slitt AL, Maher JM, Zhang XX, Zhang J, Huang W et al. Induction of multidrug resistance protein 3 (mrp3) in vivo is independent of constitutive androstane receptor. Drug Metab Dispos 2003;31:1315-9.
48. Frye RF, Kroboth PD, Kroboth FJ, Stone RA, Folan M, Salek FS et al. Sex differences in the pharmacokinetics of dehydroepiandrosterone (DHEA) after single- and multiple-dose administration in healthy older adults. J Clin Pharmacol 2000;40:596-605.
49. Hobe G, Hillesheim HG, Schon R, Reddersen G, Knappe R, Bannasch P et al. Sex differences in dehydroepiandrosterone metabolism in the rat: different plasma levels following ingestion of DHEA-supplemented diet and different metabolite patterns in plasma, bile and urine. Horm Metab Res 1994;26:326-9.
50. Hobe G, Hillesheim HG, Schon R, Undisz K, Valentin U, Reddersen G et al. Studies on the metabolism of DHEA in rat and mice. Berlin: Walter de Gruyter;2000.
51. Longcope C. Metabolism of dehydroepiandrosterone. Ann N Y Acad Sci 1995;774:143-8.
52. Ripp SL, Falkner KC, Pendleton ML, Tamasi V, Prough RA. Regulation of CYP2C11 by dehydroepiandrosterone and peroxisome proliferators: identification of the negative regulatory region of the gene. Mol Pharmacol 2003;64:113-22.
53. Gu S, Ripp SL, Prough RA, Geoghegan TE. Dehydroepiandrosterone affects the expression of multiple genes in rat liver including 11 beta-hydroxysteroid dehydrogenase type 1: a cDNA array analysis. Mol Pharmacol 2003;63:722-31.
54. Ripp SL, Fitzpatrick JL, Peters JM, Prough RA. Induction of CYP3A expression by dehydroepiandrosterone: involvement of the pregnane X receptor. Drug Metab Dispos 2002;30:570-5.
55. Teng S, Jekerle V, Piquette-Miller M. Induction of ABCC3 (MRP3) by pregnane X receptor activators. Drug Metab Dispos 2003;31:1296-9.
56. Fujita A, Furutama D, Tanaka T, Sakai R, Koyama A, Hanafusa T et al. In vivo activation of the constitutive androstane receptor beta (CARbeta) by treatment with dehydroepiandrosterone (DHEA) or DHEA sulfate (DHEAS). FEBS Lett 2002;532:373-8.
57. Borst P, Evers R, Kool M, Wijnholds J. The multidrug resistance protein family. Biochem Biophys Acta 1999;1461:347-57.